Secondary Logo

Journal Logo

Articles by Sebastian Mirkin, MD

Early onset of action with a 17β-estradiol, softgel, vaginal insert for treating vulvar and vaginal atrophy and moderate to severe dyspareunia

Constantine, Ginger; Millheiser, Leah S.; Kaunitz, Andrew M.; More

Menopause. ., Post Author Corrections: August 19, 2019

Estradiol and progesterone bioavailability for moderate to severe vasomotor symptom treatment and endometrial protection with the continuous-combined regimen of TX-001HR (oral estradiol and progesterone capsules)

Lobo, Rogerio A.; Liu, James; Stanczyk, Frank Z.; More

Menopause. 26(7):720-727, July 2019.

In Reply

Archer, David F.; Constantine, Ginger D.; Simon, James; More

Menopause. 24(8):988-989, August 2017.

The REJOICE trial: a phase 3 randomized, controlled trial evaluating the safety and efficacy of a novel vaginal estradiol soft-gel capsule for symptomatic vulvar and vaginal atrophy

Constantine, Ginger D.; Simon, James A.; Pickar, James H.; More

Menopause. 24(4):409-416, April 2017.

A 7-year randomized, placebo-controlled trial assessing the long-term efficacy and safety of bazedoxifene in postmenopausal women with osteoporosis: effects on bone density and fracture

Palacios, Santiago; Silverman, Stuart L.; de Villiers, Tobie J.; More

Menopause. 22(8):806-813, August 2015.

Effect of tibolone and its metabolites on vascular endothelial growth factor isoforms 121 and 165 and thrombospondin-1 mRNA in Ishikawa cells

Mirkin, Sebastian; Mahony, Mary C.; Archer, David F.

Menopause. 11(1):82-88, January-February 2004.

Show: